Related Experiment Video

Updated: Jul 17, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Malignancies of the head and neck: the role for molecular targeted agents

Mark Agulnik1

  • 1Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology, 676 North St. Clair Street, Suite 850, Chicago, IL 60611, USA. m-agulnik@northwestern.edu

Expert Opinion on Therapeutic Targets
|January 18, 2007
PubMed

Insights

Molecularly targeted agents offer new hope for advanced head and neck cancers, including squamous cell carcinoma. These therapies aim to improve survival rates by targeting cancer

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Head and neck cancers, including squamous cell carcinoma, nasopharyngeal, and salivary gland carcinomas, present a significant challenge due to poor survival rates in advanced stages.
  • Current treatment strategies require evolution to improve outcomes for patients with recurrent or metastatic disease.

Purpose of the Study:

  • To review the role of molecularly targeted agents in treating head and neck cancers.
  • To explore the potential of these novel agents to enhance the current standard of care.

Main Methods:

  • Literature review of studies on molecularly targeted agents for head and neck malignancies.
  • Analysis of genetic and epigenetic aberrations driving cancer evolution.
  • Exploration of therapeutic strategies targeting oncogenic processes.

Main Results:

  • Molecularly targeted agents represent a promising therapeutic avenue for head and neck cancers.
  • These agents offer the potential to restore normal cellular control, counteracting oncogenic processes.
  • Evidence suggests these novel therapies could improve upon existing treatment standards.

Conclusions:

  • Molecularly targeted agents hold significant promise for improving treatment outcomes in advanced head and neck cancers.
  • Further research and clinical application of these agents are crucial for enhancing patient survival.
  • Targeting specific molecular pathways offers a more precise approach to managing these complex malignancies.

More Related Videos

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...